A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma

OBJECT: Early-phase clinical studies of glioma vaccines have shown feasibility and encouraging preliminary clinical activity. A vaccine that targets tumor angiogenesis factors in glioma microenvironment has not been reported. Therefore, we performed a pilot study to evaluate the safety and immunogen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Shibao, Shunsuke, Ueda, Ryo, Saito, Katsuya, Kikuchi, Ryogo, Nagashima, Hideaki, Kojima, Atsuhiro, Kagami, Hiroshi, Pareira, Eriel Sandika, Sasaki, Hikaru, Noji, Shinobu, Kawakami, Yutaka, Yoshida, Kazunari, Toda, Masahiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2018
Gaiak:
Clinical Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940381/
https://ncbi.nlm.nih.gov/pubmed/29765561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25131
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak